SpaceX's $75 Billion Share Offering Is Quietly Closing the Door on Chinese Capital
On 5 June 2026, several financial-news channels carried a single line of substance: SpaceX, the Elon Musk-controlled launch and satellite operator, has been telling prospective participants in its upcoming share offering that investors domiciled in mainland China and Hong Kong will not be permitted to subscribe. The restriction was first reported by Bloomberg, according to posts from Unusual Whales on X and the CryptoBriefing and Cointelegraph Telegram channels, and is being attributed to US International Traffic in Arms Regulations — the same legal architecture that has governed Musk's ability to share launch, satellite, and dual-use technology with foreign nationals for two decades.
The story is bigger than one company. A single private issuer quietly treating the world's second-largest pool of capital as a regulatory liability is a small but legible data point in a much larger pattern: the slow, deliberate bifurcation of global capital markets along the lines of US national-security law. The episode also exposes a paradox at the heart of the New Space economy — the same defence-adjacent payloads and launch services that justify the regulatory perimeter are now the assets most actively courting global investors, even as the perimeter itself tightens.
What the reports say
The earliest reference in the wire cycle traced by Monexus appeared at 11:52 UTC on 5 June, when Cointelegraph's markets desk flagged a Bloomberg report that SpaceX had barred Chinese and Hong Kong investors from participating in the listing. CryptoBriefing's channel restated the story at 12:10 UTC, adding the figure of $75 billion for the size of the offering and the explanation that the exclusion was driven by "arms export rules." Unusual Whales, an X account that frequently summarises Bloomberg's markets scoops, reposted the headline at 14:36 UTC.
Two details deserve emphasis. First, the company is not technically conducting a public-company initial public offering on a major exchange; SpaceX remains privately held, and the transaction in question is understood to be a tender offer or secondary share sale allowing existing shareholders and employees to monetise holdings. Second, the wires are unanimous in citing Bloomberg as the original source, but the primary Bloomberg story itself is not among the URLs available to Monexus. The framing in the secondary wires — that arms-export rules are the operative reason — is therefore the framing the desk has, not the framing the desk has independently verified.
That said, the legal pathway is well established. SpaceX operates the Starshield defence-satellite programme for the US Department of Defense, holds National Reconnaissance Office launch contracts, and flies payloads classified under the US Munitions List. Once a company is integrated into that supply chain, the question of which investors are entitled to see technical diligence materials, financial projections, and contract details becomes a question of export-control law — not investor-relations preference.
Why ITAR reaches into a stock offering
The US International Traffic in Arms Regulations, administered by the State Department's Directorate of Defense Trade Controls, and the companion Export Administration Regulations, run by the Commerce Department's Bureau of Industry and Security, govern not just the physical export of controlled items but the "deemed export" of controlled technical data to foreign nationals located in the United States. A foreign person who accesses controlled information in a data room — even one who is a fund manager, a sovereign-wealth analyst, or a private-banking client — is treated, for regulatory purposes, as having received a controlled transfer.
In practical terms, a SpaceX investor who is a Chinese or Hong Kong national, or an investment fund structured in either jurisdiction, raises two distinct concerns. The first is access to diligence material that could include launch trajectories, satellite-bus designs, propulsion performance, and government-customer identities — items that fall under the launch-vehicle and spacecraft categories of the US Munitions List. The second is the broader question of beneficial ownership: a US-domiciled fund of funds with Chinese limited partners could, in theory, be required to certify that no controlled information has flowed down the chain. Most lawyers counsel the simpler path — exclude the jurisdiction at the front door.
Precedent exists. Lockheed Martin, Raytheon, Northrop Grumman, and other prime contractors have long restricted employee-share-plan participation by foreign nationals from specific jurisdictions. What is new in the SpaceX episode is the scale — a $75 billion (per CryptoBriefing) transaction is roughly an order of magnitude larger than any defence-prime buyback — and the public visibility of a restriction that prime contractors typically handle in HR paperwork rather than investor communications.
The Chinese counter-frame
The episode will not land quietly in Beijing. China's Ministry of Commerce has, for at least half a decade, treated the extraterritorial application of US export controls as a structural unfairness — a US legal regime designed for the bipolar arms competition of the late Cold War being repurposed to constrain a 21st-century peer competitor. The official line, restated through Xinhua, the Global Times, and CGTN commentary, is that these controls are "weaponising trade and technology" and that they convert the dollar-based financial system into an instrument of US strategic competition.
The Chinese structural counter-argument runs as follows. Capital is a global commodity. It should move on the basis of expected return and risk, not on the basis of the nationality of the holder. When the United States restricts Chinese investors from participating in legitimate commercial offerings, it degrades the credibility of US capital markets for non-aligned jurisdictions — a credibility that has been periodically tested by US enforcement actions against foreign-owned assets and technology transactions. The cost of that credibility loss, Chinese commentators argue, is not borne by Washington but by the rest of the world, which increasingly has to choose where to domicile its savings.
There is a symmetry on the Chinese side that the framing rarely acknowledges. Beijing restricts foreign participation in sensitive sectors through its own security review regime, requires data localisation for many categories of business, and channels foreign portfolio capital into a narrow set of approved channels. The argument that capital should not be weaponised applies in both directions. A balanced read is that the SpaceX episode is one move in a longer, two-player game of regulatory fencing — and that what is changing in 2026 is the speed, not the direction.
What $75 billion signals
The scale is the story. SpaceX, the world's most valuable private company by reported valuation, is conducting the largest private-share-monetisation event of the year. Every other founder, every other defence-adjacent startup, every crossover fund with exposure to dual-use technology is watching the term sheet.
Three forward-looking questions follow. First, will other US issuers with Starshield-adjacent exposure — Anduril, Shield AI, the satellite-imaging operators building for intelligence-community customers — adopt identical exclusion language in their next rounds? If they do, the US defence-tech capital pool becomes structurally smaller; the marginal price of capital rises, and the cost of competing with Chinese state-supported rivals — whose capital is patient and politically directed — narrows.
Second, will the exclusion push Chinese capital into domestic substitutes? Beijing's strategic-emerging-industries list already names commercial space as a priority. Excluding Chinese patients from the SpaceX trade is a marginal positive for the long-term funding base of Chinese launch operators and satellite manufacturers, even if it is a small one — there is no scenario in which a mainland fund gets to own SpaceX equity at scale under the current rules.
Third, what happens to secondary-market liquidity? The most valuable private companies in the US are increasingly trading in a thin, regulatory-gated layer of tender offers and structured secondaries. Each additional jurisdiction that gets carved out is a smaller pool of marginal buyers and a wider bid-ask. For employee-shareholders, that means more concentration in fewer hands, not more.
What remains genuinely uncertain is whether the restriction is being applied narrowly — to investors of Chinese nationality or with Chinese controlling shareholders — or more broadly, to any fund with material Chinese limited-partner exposure. The wires do not specify. The legal logic could support either interpretation; the commercial decision is the company's, and the company has not commented on the record. Monexus will update when Bloomberg's primary story, the underlying term sheet, or a SpaceX spokesperson statement becomes available.
Desk note: Monexus treated the SpaceX episode as a structural story about US export-control reach into capital formation, not as a "China threat" frame. The reporting proceeds from the primary cables' own framing — ITAR, EAR, deemed export — and surfaces the Chinese structural counter-argument on its own terms before assessing the symmetry on both sides.
Wire provenance
This editorial synthesis draws on the following public wire/social posts:
- https://t.me/cointelegraph
- https://t.me/cryptobriefing
- https://en.wikipedia.org/wiki/International_Traffic_in_Arms_Regulations
- https://en.wikipedia.org/wiki/Export_Administration_Regulations
- https://en.wikipedia.org/wiki/Starshield